Identification of four genes associated with cutaneous metastatic melanoma
Ji Chen,
Li Yuming,
Yang Kai,
Gao Yanwei,
Sha Yan,
Xiao Dong,
Liang Xiaohong,
Cheng Zhongqin
Affiliations
Ji Chen
Department of Dermatology, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, 77 Changan South Road, Zhangjiagang, Jiangsu Province, 215600, China
Li Yuming
Department of Dermatology, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, 77 Changan South Road, Zhangjiagang, Jiangsu Province, 215600, China
Yang Kai
Department of Dermatology, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, 77 Changan South Road, Zhangjiagang, Jiangsu Province, 215600, China
Gao Yanwei
Department of Dermatology, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, 77 Changan South Road, Zhangjiagang, Jiangsu Province, 215600, China
Sha Yan
Department of Dermatology, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, 77 Changan South Road, Zhangjiagang, Jiangsu Province, 215600, China
Xiao Dong
Department of Dermatology, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, 77 Changan South Road, Zhangjiagang, Jiangsu Province, 215600, China
Liang Xiaohong
Department of Pulmonary and Critical Care Medicine, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, 77 Changan South Road, Zhangjiagang, Jiangsu Province, 215600, China
Cheng Zhongqin
Department of Dermatology, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, 77 Changan South Road, Zhangjiagang, Jiangsu Province, 215600, China
Cutaneous melanoma is an aggressive cancer with increasing incidence and mortality rates worldwide. Metastasis is one of the primary elements that influence the prognosis of patients with cutaneous melanoma. This study aims to clarify the potential mechanism underlying the low survival rate of metastatic melanoma and to search for novel target genes to improve the survival rate of patients with metastatic tumors.
